Di Fan, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste 201b, Elk Grove Village, IL 60007 Phone: 847-593-8460 Fax: 224-235-4652 |
News Archive
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 363-373(11); DOI: https://doi.org/10.15212/CVIA.2017.0079 Khadeeja Esmail and Dominick J. Angiolillo from the University of Florida Medical School, Gainesville, FL, USA review antiplatelet therapy considerations in women.
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer Institute (NCI).
As many as 50 per cent of people bring their work home with them regularly, according to new research out of the University of Toronto that describes the stress associated with work-life balance and the factors that predict it.
› Verified 5 days ago